Tanja Podkonjak

3PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 04, 2022
Brentuximab Vedotin Plus CHP in Frontline sALCL: Adjusted Estimates of Efficacy and Cost-Effectiveness Removing the Effects of Re-Treatment with Brentuximab Vedotin.

Holly Cranmer, David Trueman, Elise Evers

|Dec 09, 2021
Cost-effectiveness of brentuximab vedotin for the treatment of cutaneous T-cell lymphoma.

Tanja Podkonjak, Holly Cranmer, Julia Scarisbrick

|Jul 11, 2020
Real-world evidence use in assessments of cancer drugs by NICE.

Ash Bullement, Tanja Podkonjak, Mark J Robinson

Pageof 1

Frequent Collaborators

1 joint publications

Ash Bullement

1 joint publications

Mark J Robinson

1 joint publications

Anthony J Hatswell

1 joint publications

Gemma E Shields